Medical Devices
Technology
Health

Cooper

$291.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.49 (-1.85%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Cooper and other stocks, options, ETFs, and crypto commission-free!

About

The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. Read More The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical business unit focuses on supplying women's health clinicians with market medical products and treatment options to improve the delivery of healthcare to women. The company was founded in 1958 and is headquartered in Pleasanton, CA.

Employees
12,000
Headquarters
Pleasanton, California
Founded
1958
Market Cap
14.65B
Price-Earnings Ratio
39.76
Dividend Yield
0.02
Average Volume
380.54K
High Today
$297.45
Low Today
$291.61
Open Price
$296.63
Volume
62.41K
52 Week High
$299.00
52 Week Low
$216.47

Collections

Medical Devices
Technology
Health
Medical
Healthcare
US
North America

News

Yahoo FinanceMar 21

Cooper Companies' (COO) CooperVision Gains Momentum Globally

The Cooper Companies Inc. COO has been an active player in addressing the global epidemic of myopia disease. Recently, the company announced that its CooperVision unit is steadily taking multiple initiatives to increase adoption of its innovative MiSight 1 day product across major world markets. This apart, CooperVision’s Eye care professional (ECP)-focused standards development and educational programs are gaining traction globally. CooperVision’s Global Foothold Strong Scroll to continue with content A...

4
PR NewswireMar 18

CooperVision's Innovative MiSight® 1 Day Contact Lenses Gain Momentum in Key European, Canadian and Asia-Pacific Markets

PLEASANTON, Calif., March 18, 2019 /PRNewswire/ -- Multiple new CooperVision initiatives in major world markets are providing a glimpse at the company's commitment to addressing the global myopia epidemic. Central to the effort are programs designed to increase adoption of its innovative MiSight® 1 day product, which is the world's first 1-day soft contact lens proven to substantially slow the progression of myopia in children.1,2 Eye care professional (ECP)-focused standards development and educational pr...

0
Yahoo FinanceMar 14

CooperVision Voices Support for International Myopia Institute White Papers

Global Experts Release Highly-Anticipated White Papers on Myopia Management PLEASANTON, Calif., March 14, 2019 /PRNewswire/ -- Affirming its role as a global leader in myopia management, CooperVision is voicing strong support for the publication of eight highly-anticipated white papers by the International Myopia Institute (IMI). Released within the past several days, the reports cover a range of topics deemed essential to advancing clinical knowledge and practice relating to stemming the expanding impact ...

7

Earnings

$2.50
$2.69
$2.88
$3.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jun 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.